EU Drugs Agency Endorses Alcon Glaucoma Treatment | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Monday, September 29, 2008

Email

Comments

Reuters

The European Medicines Agency has recommended approval of Alcon's (ACL.N: Quote, Profile, Research, Stock Buzz) glaucoma treatment Azarga.

Glaucoma Testing Equipment / Glaucoma Products »

The patient in the photos below is a 45 yo female with complaints of a bulging right eye that has been gradual over the past several years. She denies pain or double vision. Her CT scans are shown below as well as the surgical removal of the tumor. What is the most likely diagnosis?
1. schwannoma
2. cavernous hemangioma
3. capillary hemangioma
4. metastatic breast cancer
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us